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Abstract: We report the analysis of activation by corticosteroids and progesterone of full-length 
mineralocorticoid receptor (MR) from elephant shark, a cartilaginous fish belonging to the oldest 
group of jawed vertebrates.  Based on their measured activities, aldosterone, cortisol, 11-
deoxycorticosterone, corticosterone, 11-deoxcortisol, progesterone and 19-norprogesterone are 
potential physiological mineralocorticoids.  However, aldosterone, the physiological 
mineralocorticoid in humans and other terrestrial vertebrates, is not found in cartilaginous or ray-
finned fishes.  Because progesterone is a precursor for corticosteroids that activate elephant shark 
MR, we propose that progesterone was an ancestral ligand for elephant shark MR.  Although 
progesterone activates ray-finned fish MRs, progesterone does not activate human, amphibian or 
alligator MRs, suggesting that during the transition to terrestrial vertebrates, progesterone lost the 
ability to activate the MR.  Comparison of RNA-sequence analysis of elephant shark MR with 
that of human MR suggests that MR expression in the human brain, heart, ovary, testis and other 
non-epithelial tissues evolved in cartilaginous fishes.  Together, these data suggest that 
progesterone-activated MR may have unappreciated functions in elephant shark ovary and testis. 
 
Introduction 
The mineralocorticoid receptor (MR) belongs to the nuclear receptor family, a large and 
diverse group of transcription factors that also includes receptors for glucocorticoids (GR), 
progesterone (PR) androgens (AR) and estrogens (ER) (1, 2).  Sequence analysis revealed that 
the MR and GR are closely related (3); phylogenetic analysis indicates that MR and GR evolved 
from a corticosteroid receptor (CR) that was present in jawless vertebrates, such as lamprey and 
hagfish (4-7).  A distinct mineralocorticoid receptor (MR) first appears in cartilaginous fishes 
(Chondrichthyes), the oldest group of extant jawed vertebrates (gnathostomes) that diverged 
from bony vertebrates about 450 million years and are a crucial group in understanding the 
origin and evolution of jawed vertebrate morphology and physiology (8, 9).  Like mammals, 
cartilaginous fishes contain the full complement of adrenal and sex steroid receptors: AR, ER, 
GR, MR and PR (1, 2, 4, 10). 
Aldosterone (Aldo) is the physiological activator of transcription of human MR in 
epithelial tissues, such as the kidney distal collecting tubules and the colon, in which the MR 
regulates electrolyte homeostasis (6, 11-14).  The MR also is found in brain, heart, aorta, lung, 
liver, spleen, adipose tissue, testis, breast and ovary (12-20), tissues in which the MR is not 
likely to regulate electrolyte homeostasis, its classical function.  The physiological function of 
the MR in these tissues is still being elucidated (14, 18, 20, 21). 
The MR and other steroid receptors have a characteristic modular structure consisting of 
an N-terminal domain (NTD) (domains A and B), a central DNA-binding domain (DBD) 
(domain C), a hinge domain (D) and a C-terminal ligand-binding domain (LBD) (domain E) (2, 
4, 22-24) (Figure 1).  The E domain alone is competent to bind steroids (4, 22, 25-27).  
Interactions between the NTD (A/B domains) and the LBD and coactivators are important 
regulators of transcriptional activation of mammalian MRs (28-35) and fish MRs (34-36).  
Moreover, GAL-DBD-hinge-LBD constructs of zebrafish MR have different responses to 
progesterone (Prog) and some corticosteroids than do GAL-DBD-hinge-LBD constructs of 
human, chicken, alligator and Xenopus MRs (35). 
The timing of the evolution of this difference in transcriptional activation between full-
length and truncated MRs in ray-finned fishes and terrestrial vertebrates, as well as when 
expression of the MR in non-epithelial tissues evolved is not known.  Also unresolved is the 
identity of the ancestral mineralocorticoid in cartilaginous fishes and the current 
mineralocorticoid in ray-finned fish because aldosterone (Aldo), the physiological 
mineralocorticoid in terrestrial vertebrates, is not found in cartilaginous fishes or ray-finned 
fishes.  Aldo first appears in lobe-finned fish (37), the forerunners of terrestrial vertebrates (38).  
Thus, the identity of the physiological mineralocorticoid in cartilaginous fishes and ray-finned 
fishes is not established, although cortisol and 11-deoxycorticosterone have been proposed (39-
45). 
 
Figure 1. Comparison of domains in elephant shark MR with vertebrate MRs.  MRs from elephant shark 
(shark), zebrafish, coelacanth, Xenopus (frog), chicken and human are compared.   The functional A/B domain 
to E domains are schematically represented with the numbers of amino acid residues and the percentage of 
amino acid identity is depicted.  GenBank accession numbers: elephant shark MR (XP_007902220), zebrafish 
MR (NP_001093873), coelacanth MR (XP_014348128), Xenopus (NP_001084074), chicken (ACO37437), 
human MR (NP_000892). 
 
Complicating the identity of the physiological mineralocorticoid in cartilaginous and ray-
finned fishes is evidence that progesterone (Prog) and 19-norprogesterone (19norProg), along 
with spironolactone (Spiron) (Figure 2), are transcriptional activators of several ray-finned fish 
MRs (24, 36, 44), including zebrafish MR (35, 46), and of chicken MR (35).  In contrast, these 
steroids are antagonists for human MR (25, 27, 47), alligator MR and Xenopus MR (35).  Ray-
finned fish MRs and chicken MR differ in their response to Prog, 19norProg and Spiron, raising 
the question of whether the response to Prog and Spiron evolved in ray-finned fish before or after 
the divergence of ray-finned fish from the lobe-finned fish lineage that led to tetrapods. 
 
 
Figure 2. Structures of steroids that are ligands for the MR.  Aldo, 11-deoxycorticosterone and S are 
physiological mineralocorticoids in terrestrial vertebrates (4, 6, 12, 48).  S is both a mineralocorticoid and 
a glucocorticoid in lamprey (4, 49) and a glucocorticoid in ray-finned fish (50).  Cortisol is a 
physiological glucocorticoid in terrestrial vertebrates and ray-finned fish (4, 10, 51-53).  corticosterone is 
a glucocorticoid in rats and mice (4).  Aldo, 11-deoxycorticosterone, cortisol, corticosterone and Prog 
have a similar high affinity for human MR (3, 54-56).  Prog, 19norProg, 17OH-Prog and Spiron are 
antagonists for human MR (24, 47, 54) and rat MR (57, 58).  Prog, 19norProg, and Spiron are agonists for 
fish MRs (24, 36, 44).  19norProg is a weak agonist for rat MR (59, 60). 
 
Transcriptional activation by corticosteroids and other 3-ketosteroids of a full-length 
cartilaginous fish MR, which is the physiological MR, has not been investigated.  Only truncated 
skate MR (61), consisting of the GAL4 DBD fused to the D domain and E domain of the MR 
(MR-LBD) has been studied for its response to corticosteroids.  In these studies, Carroll et al. 
found that Aldo, corticosterone, 11-deoxycorticosterone, and cortisol (Figure 2) are 
transcriptional activators of truncated skate MR. 
Elephant shark MR is an attractive receptor to study early events in the evolution of 
mechanisms for regulating MR transcription because, in addition to its phylogentic position as a 
common ancestor of ray-finned fish and terrestrial vertebrates, genomic analyses reveal that 
elephant shark genes are evolving slowly (9), making their genes windows into the past.  Thus, 
we investigated transcriptional activation by Aldo, 11-deoxycorticosterone, corticosterone, 11-
deoxycortisol, cortisol, Prog, 19norProg, 17-hydroxyprogesterone (17OH-Prog) and Spiron of 
full-length and truncated elephant shark MR.  Interestingly, all 3-ketosteroids, including 
progesterone, had EC50s of 1 nM or lower for full-length elephant shark MR.  Transcriptional 
activation by Prog, 19norProg and Spiron of truncated elephant shark MR resembled that of 
zebrafish MR and not chicken MR, indicating that Prog activation of MR is an ancestral 
response, conserved in ray-finned fish, lost in Xenopus, alligator and human MRs, and distinct 
from activation of chicken MR, which arose independently.  We also performed RNA-seq 
analysis of elephant shark MR and find widespread expression of MR in various elephant shark 
tissues (gill, kidney, heart, intestine, liver, spleen, brain, ovary and testis).  This indicates that 
widespread expression of human MR in tissues, such as brain, heart, liver, spleen, ovary and 
testis, in which the MR does not regulate electrolyte homeostasis, evolved early in vertebrate 
evolution, in an ancestral cartilaginous fish.  Strong MR expression in ovary and testis suggests a 
role for Prog-MR complexes in elephant shark reproduction, as well as other novel functions in 
some other MR-containing tissues.  Finally, our data suggest that Prog or a related steroid may 
have been one of the ancestral mineralocorticoids. 
 
Results 
Functional domains of elephant shark MR and other vertebrate MRs. 
In Figure 1, we compare the functional domains of elephant shark MR to selected 
vertebrate MRs.  Elephant shark MR and human MR have 92% and 67% identity in DBD and 
LBD, respectively.  Interestingly, elephant shark MR has similar conservation to the DBD (91-
92%) and LBD (64-69%) of other MRs.  The A, B and D domains of elephant shark MR and 
other MRs are much less conserved. 
Transcriptional activation of full-length and truncated elephant shark MR by 
corticosteroids, progesterone and spironolactone. 
We screened a panel of steroids at 0.1 nM and 1 nM for transcriptional activation of full-
length and truncated elephant shark MR.  Aldo, cortisol, corticosterone, 11-deoxycorticosterone 
and 11-deoxycortisol were strong activators of full-length elephant shark MR (Figure 3A) 
indicating that elephant shark MR has broad specificity for corticosteroids.  Interestingly, at 
these low concentrations, Prog, 19norProg and Spiron are transcriptional activators of full-length 
elephant shark MR, with 19norProg having the strongest activity and 17OHProg having the 
weakest activity (Figure 3A). 
In parallel experiments, truncated elephant shark MR, lacking the A/B domain and 
containing a GAL4-DBD instead of the MR DBD, retained a strong response to all 
corticosteroids and 19nor Prog (Figure 3B).  Prog and Spiron had significant, but reduced 
activity, while 17OH-Prog had little activity for truncated elephant shark MR. 
 
Figure 3. Transcriptional activation of elephant shark MR by 3-ketosteroids.  Full length and 
truncated elephant shark MR were expressed in HEK293 cells with an MMTV-luciferase reporter. 
A. Full length elephant shark MR.  Cells were treated with 0.1 nM or 1.0 nM Aldo, cortisol, 
corticosterone, 11-deoxycorticosterone, 11-deoxycortisol, Prog, 19norProg (19NP), 17OH-Prog, Spiron 
or vehicle alone (DMSO). 
B. Truncated elephant shark MR.  Cells were treated with 0.1 nM or 1.0 nM Aldo, cortisol, 
corticosterone, 11-deoxycorticosterone, 11-deoxycortisol, Prog, 19norProg (19NP), 17OH-Prog or Spiron 
or vehicle alone (DMSO).  Results are expressed as means ± SEM, n=3.  Y-axis indicates fold-activation 
compared to the activity of control vector with vehicle (DMSO) alone as 1. 
 
EC50 values for steroid activation of elephant shark MR 
Concentration-dependence of transcriptional activation of full length elephant shark MR 
by corticosteroids (Aldo, cortisol, corticosterone, 11-deoxycorticosterone, 11-deoxycortisol) is 
shown in Figure 4A and by Prog, 19norProg, 17OH-Prog and Spiron in Figure 4B.  The 
corresponding concentration-dependent curves for truncated elephant shark MR are shown in 
Figures 4C and 4D, respectively.  Table 1 summarizes the EC50s of corticosteroids for full-
length and truncated elephant shark MR.  Table 1 also contains, for comparison, previously 
determined EC50s of corticosteroids for full-length and truncated human, chicken, alligator, 
Xenopus and zebrafish MRs (35) and skate MR (61). 
 
Figure 4. Concentration-dependent transcriptional activation of full-length and truncated elephant 
shark MR (shark MR) by 3-ketosteroids.  Full length and truncated elephant shark MR (shark MR) 
were expressed in HEK293 cells with an MMTV-luciferase reporter.  Full-length elephant shark MR 
(shark MR) (A) and (C) and truncated elephant shark MR (shark MR) (B) and (D). 
(A), (B) Aldo, cortisol, corticosterone, 11deoxycorticosterone or 11-deoxycortisol. 
(C), (D) Aldo, Prog, 19norProg (19nor-P), 17OH-Prog (17OH-P) or Spiron.  Cells transfected with 
elephant shark MR were treated with increasing concentrations of cortisol, corticosterone, Aldo, 
11deoxycorticosterone, 11-deoxycortisol, Prog, 19norProg, 17OH-Prog, Spiron or vehicle alone (DMSO).  
Y-axis indicates fold-activation compared to the activity of control vector with vehicle (DMSO) alone as 
1. 
 
Table 1. Corticosteroid activation of full-length MR and GAL4-DBD-MR-LBD 
MR Aldo B F DOC S 
EC50 (M) EC50 (M) EC50 (M) EC50 (M) EC50 (M) 
Elephant shark Full 1.1 x 10-10 1.7 x 10-10 4.6 x 10-10 6.3 x 10-11 1.1 x 10-10 
 100% 101% 114% 83% 83% 
Elephant shark LBD 3.7 x 10-11 9.9 x 10-11 1.9 x 10-10 2.4 x 10-11 6.8 x 10-11 
 100% 90% 79% 81% 77% 
1
Skate LBD 7 x 10
-11 1 x 10-10 1 x 10-9 3 x 10-11 2.2 x 10-8 
2
Human Full 
 
2.7 x 10-10 1.2 x 10-9 5.5 x 10-9 4.2 x 10-10 3.6 x 10-9 
100% 119% 133% 74% 42% 
2
Human LBD 2.8 x 10
-10 5.9 x 10-10 3. x 10-9 1.8 x 10-9 #- 
100% 95% 74% 44% *8% 
2
Chicken Full 6.2 x 10
-11 5.1 x 10-11 2.8 x 10-10 3.4 x 10-11 6.7 x 10-10 
100% 109% 128% 110% 112% 
2
Chicken LBD 1.3 x 10
-10 1.6 x 10-10 6.9 x 10-10 1.7 x 10-10 4.7 x 10-9 
100% 92% 75% 92% 36% 
2
Alligator-Full 2.8x 10
-10 3.6 x 10-10 6.9x 10-9 2.3 x 10-10 2.7 x 10-9 
100% 138% 176% 85% 45% 
2
Alligator LBD 3.5 x 10
-10 3.8 x 10-10 2.3 x 10-9 5.2 x 10-10 #- 
100% 88% 68% 51% *8% 
2
Xenopus Full 4.6 x 10
-10 6.2 x 10-10 1.1 x 10-8 7.6 x 10-10 9.1 x 10-9 
100% 105% 126% 59% 31% 
2
Xenopus-LBD 1.5 x 10
-9 1.9 x 10-9 1.2 x 10-8 #- #- 
100% 74% 37% *10% *6% 
2
Zebrafish Full 8.2 x 10
-11 3.0 x 10-10 4.4 x 10-10 6.3 x 10-11 4.0 x 10-10 
100% 112% 123% 103% 94% 
2
Zebrafish LBD 2.7 x 10
-11 1.5 x 10-10 3.1 x 10-10 1.0 x 10-10 9.1 x 10-10 
100% 96% 77% 99% 67% 
1 (61) 
2 (35) 
# Curve did not saturate. 
(%) Relative induction to Aldosterone induced activation. 
* Relative induction at 1 µM compared to Aldo. 
 
Previously we reported that Prog, 19norProg and Spiron are transcriptional activators of 
full-length chicken and zebrafish MRs and truncated zebrafish MR (35).  However, EC50 values 
of Prog, 19norProg and Spiron for these MR were not determined.  We have remedied this 
omission and report their EC50 values in Table 2 and Figure 5, for comparison with full-length 
and truncated elephant shark MR. 
 
Figure 5. Concentration-dependent transcriptional activation of full-length and truncated chicken 
and zebrafish MR by progestins and Spironolactone.  HEK293 cells transfected with chicken and 
zebrafish MR were treated with increasing concentrations of Prog, 19norProg, 17OH-Prog or Spiron.  
Full-length chicken MR (A) and zebrafish MR (B) and truncated chicken MR (C) and zebrafish MR (D).  
Y-axis indicates fold-activation compared to the activity of control vector with vehicle (DMSO) alone as 
1. 
 
Table 2. EC50 values for progestin and spironolactone activation of full-length and GAL4-
DBD-MR-LBD constructs of elephant shark, zebrafish and chicken MR 
MR Aldo Prog 17OH-Prog 19norProg Spiron 
Elephant shark Full 1.1 x 10-10 2.7 x 10-10 1.4 x 10-9 4.3 x 10-11 5.5 x 10-10 
 100% 43% 25% 84% 45% 
Elephant shark LBD 3.7 x 10-11 4.8 x 10-10 2.9 x 10-9 1.8 x 10-11 4.2 x 10-10 
 100% 40% 26% 98% 53% 
2
Zebrafish Full 8.2 x 10
-11 2.4 x 10-9 1.8 x 10-8 9.4 x 10-10 3.8 x 10-9 
 100% 77% 44% 83% 54% 
2
Zebrafish LBD 2.7 x 10
-11 9.8 x 10-8 #- 6.4 x 10-8 #- 
 100% 122% *24% 122% *73% 
2
Chicken Full 6.2 x 10
-11 7.1 x 10-10 2.9 x 10-8 6.8 x 10-10 5.1 x 10-9 
 100% 62% 15% 68% 30% 
2
Chicken LBD 1.3 x 10
-10 #- #- #- #- 
 100% *21% - *29% - 
2 (35) # Curve did not saturate. 
(%) Relative induction to Aldosterone induced activation. 
* Relative induction at 1 µM compared to Aldo. 
 
 
RNA-seq analysis of elephant shark MR 
We examined expression of level of elephant shark MR gene in 10 tissues based on 
RNA-seq data (Figure 6A).  The MR gene was found to express widely in all tissues, including 
gills and kidney, two traditional mineralocorticoid-responsive tissues.  Interestingly there was 
considerably higher expression in the ovary and testis, the two reproductive tissues analyzed. 
 
Figure 6A. Expression level of MR gene in 10 tissues of elephant shark estimated based on RNA-seq 
data.  Transcript abundances are shown in terms of normalized counts called Fragments per kilobase of 
exon per million fragments mapped (FPKM) (62). FPKM is estimated by normalizing gene length 
followed by normalizing for sequencing depth. 
 
RNA-seq analysis of human MR 
RNA-seq analysis of human MR (63) (Figure 6B) reveals that the MR is expressed in 
kidney, colon, brain, heart, liver, ovary, spleen and testis.  This diverse pattern of expression is 
similar to that of elephant shark MR. 
 
Figure 6B. Expression level of human MR based on RNA-seq data.  Transcript abundances are shown 
in terms of normalized counts called Reads Per Kilobase of transcript per Million mapped reads (RPKM) 
(63). 
 
Discussion 
Cartilaginous fish, including elephant sharks, occupy a key position in the evolution of 
vertebrates as an out-group to ray-finned fish, the largest group of extant vertebrates, and the 
lobe-finned fish, which are the forerunners of terrestrial vertebrates.  Importantly, the elephant 
shark genome is evolving slowly (9), making it attractive for studying ancestral proteins, 
including the MR, which first appears as a distinct MR ortholog in cartilaginous fish (5, 6, 10, 
61). 
This is the first report of transcriptional activation of a full-length cartilaginous fish 
MR by a panel of five corticosteroids and Prog, 19norProg, 17OH-Prog and Spiron.  Full-length 
elephant shark MR has EC50s below 1 nM for five corticosteroids, (Figure 4, Table 1) including 
Aldo, a steroid that has not been found in cartilaginous fish.  Prog, 19norProg and Spiron also 
have sub-nM EC50s for full-length elephant shark MR.  In addition to their low EC50s, all of 
these corticosteroids and 19norProg have similar fold activation of transcription of full-length 
MR (Figure 4).  Thus, several corticosteroids, as well as 19norProg and Prog, are potential 
physiological mineralocorticoids for elephant shark MR. 
Compared to full-length elephant shark MR, the EC50s of all five corticosteroids and 
19norProg are lower for its truncated MR, while the EC50 for Spiron is slightly lower, and the 
EC50s for Prog and 17OH-Prog are about 2-fold higher (Table 1, Table 2).  Compared to fold 
activation by Aldo, the responses to 11-deoxycorticosterone, S, Prog and 17OH-Prog are similar 
for full-length and truncated elephant shark MR.  However, the relative responses to 
corticosterone and cortisol of truncated elephant shark MR are 10% and 35% lower, respectively, 
(Figure 4, Table 1) and for 19norProg and Spiron, 14% and 8% higher respectively, than for full-
length elephant shark MR (Figure 4, Table 2).  Regarding truncated skate MR, most of the 
EC50s of corticosteroids (61) are similar to that for elephant shark MR (Table 1).  The exception 
is 11-deoxycortisol, which has over 200-fold higher EC50 for skate MR than for elephant shark 
MR. 
Corticosteroid Progesterone and 19norProgesterone activation of full-length and truncated 
elephant shark, terrestrial vertebrate and zebrafish MRs 
Comparison of transcriptional activation by corticosteroids, Prog and 19norProg of full-
length and truncated elephant shark MR with full-length and truncated human, chicken, alligator, 
Xenopus and zebrafish MRs (Table 1) provides insights into the evolution of regulation of 
steroid-mediated transcription of these MRs by allosteric interactions between the NTD/DBD 
and LBD.  Like elephant shark MR, truncated terrestrial vertebrate MRs and zebrafish MR have 
similar EC50s for Aldo, corticosterone and cortisol as their full-length counterparts (Table 1).  
However, the response of truncated human, alligator and Xenopus MRs to 11-deoxycortisol did 
not saturate at 1 µM, preventing us from determining the EC50 and explaining the low fold 
activation by S (Table 1).  Interestingly, truncated chicken and zebrafish MRs, which are 
activated by Prog and19norProg, have nM EC50s for 11-deoxycortisol, although fold activation 
by 11-deoxycortisol is lower than that of Aldo.  The similar activity of truncated human, alligator 
and Xenopus MRs to Aldo, corticosterone and cortisol indicates that allosteric interactions 
between the NTD and LBD are steroid-selective.  Overall, it appears that corticosteroid 
activation, especially by 11-deoxycortisol, of elephant shark MR is less sensitive to the loss of 
NTD/DBD than are human, chicken, alligator and Xenopus MRs. 
Progesterone and 19norProgesterone activation of full-length and truncated chicken and 
zebrafish MRs 
Transcriptional activation by Prog and 19norProg of chicken and zebrafish MRs differs 
from that of elephant shark MR, especially for their truncated MRs.  Although Prog, 19norProg 
and Spiron have nM EC50s for transcriptional activation of full-length chicken and zebrafish 
MRs, at 1 µM Prog 19norProg and Spiron transcriptional activation of truncated chicken MR did 
not saturate, and at 1 µM Spiron transcriptional activation of zebrafish MR did not saturate 
(Figure 5, Table 2).  Fold activation compared to Aldo by Prog, 19norProg and Spiron is 
substantially lower for truncated chicken MR and for Spiron activation of zebrafish MR.  
However, Prog and 19norProg have EC50s of 98 nM and 64 nM, respectively, for truncated 
zebrafish MR.  In this respect, truncated zebrafish MR is closer to truncated elephant shark MR 
than is truncated chicken MR.  These data suggest that transcriptional activation by Prog and 
19norProg of chicken MR appears to have evolved independently in terrestrial vertebrates. 
Progesterone may be a mineralocorticoid in cartilaginous fishes 
Prog is a precursor for the synthesis of the other corticosteroids (5, 64).  Two 
parsimonious metabolites of progesterone are 11-deoxycorticosterone (21-hydroxyprogesterone) 
and 19norProg (Figure 2), which have EC50s, 0.063 nM and 0.043 nM, respectively, for 
elephant shark MR.  These steroids have the two lowest EC50s among the tested steroids.  
Moreover, 19norProg evokes a stronger response from elephant shark MR than Aldo (Figure 4A, 
B).  C19 demethylase activity has been found in mammalian kidney (59).  If C19 demethylase is 
present in elephant shark, then 19norProg needs to be considered as a potential physiological 
mineralocorticoid. 
The strong response to 19norProg is interesting because in vivo studies in rats revealed 
that 19norProg is at least a 100-fold weaker MR agonist than Aldo (59), while in transfected 
cells, at 1 nM, 19norProg is an antagonist (24, 47).  Unexpectedly, compared to Aldo, 19norAldo 
has less than 1% binding affinity for rat MR (65) indicating that the mechanism by which C19 
demethylation of Prog increases this steroid’s transcriptional activity for elephant shark MR is 
likely to be complex. 
We propose that transcriptional activation of elephant shark MR by 19norProg, as well as 
by Prog and Spiron, can be explained by a mechanism based on Geller et al.’s (47) discovery that 
S810L human MR mutant is transcriptionally activated by 1 nM Prog, 19norProg, and Spiron, 
unlike wild-type human MR, in which these steroids are MR antagonists.  Geller et al. used a 3D 
model of S810L MR and transcriptional analysis of a series of mutations at Ser-810 (helix 5) and 
Ala-773 (helix 3) to propose that a van der Waals contact between Leu-810 and Ala-773 was 
sufficient for transcriptional activation of S810L MR by Prog and 19norProg.  Figure 3C of 
Geller et al. (47) shows that the human S810M mutant was activated by 19norProg.  Elephant 
shark MR and skate MR contain a methionine at this position and an alanine corresponding to 
Ala-773 (Figure 7).  Based on Geller et al.’s model, we propose that transcriptional activation of 
elephant shark MR by 19norProg is due to a van der Waals contact between Met-782 (helix 5) 
and Ala-745 (helix 3), which stabilizes the A ring of 19norProg, promoting transcriptional 
activation. 
 
Figure 7. Alignment of elephant shark MR to Serine-810 and Alanine-773 in helices 3-5 in human MR. 
Elephant shark MR and skate MR contain a methionine corresponding to human Ser-810 and an alanine 
corresponding to Ala-773.  Lamprey CR and hagfish CR also contain a corresponding methionine, as well as a 
cysteine corresponding to Ala-773.  Human Ser-810 and Ala-773 are conserved in coelacanths, terrestrial vertebrate 
and ray-finned fish MRs.  Amino acids that are identical to amino acids in human MR are denoted by (-). 
 
Our results indicate that Prog activation of the MR is an ancient response.  The timing of 
evolution of Prog as an antagonist for the MR is not known.  One necessary event appears to be 
the evolution in helix 5 of a serine corresponding to serine-810 in human MR.  This occurs in 
coelacanth MR, which contains Ser-816, corresponding to human MR Ser-810 (Figure 7) and to 
elephant shark MR Met-782.  This mutation in coelacanth MR would be expected to eliminate 
the proposed van der Waals contact between helix 5 and helix 3, leading to antagonist activity of 
Prog in some terrestrial vertebrate MRs (35, 47).  However, a serine corresponding to Ser-810 in 
human MR also is present in chicken MR and ray-finned fish MRs (Figure 7), indicating another 
mechanism is involved in Prog activation of the MR in these vertebrates. 
Role for elephant shark MR in reproductive physiology 
The evidence from RNA-seq analysis of high MR expression in elephant shark ovary and 
testis (Figure 6A) suggests that a Prog-MR complex is important in reproductive responses in 
elephant shark.  Of course, Prog also acts as a reproductive steroid in ovary and testis via 
transcriptonal activation of the PR (66, 67).  Based on evidence that Prog activates the MR in 
several ray-finned fishes (24, 36, 44, 46), a Prog-MR complex also may be active in reproductive 
tissues and other tissues in ray-finned fish, as well as in cartilaginous fish. 
RNA-seq analysis also finds MR expression in elephant shark gills and kidneys (Figure 
6A), two classical targets for MR regulation of electrolyte transport (6).  Moreover, RNA-seq 
analysis also identifies MR expression in elephant shark heart and brain, two other tissues in 
which corticosteroids have important physiological actions via the MR (16-18, 20, 21, 68-70).  
Indeed, RNA seq analysis of elephant shark MR indicates that expression the MR in diverse 
tissues was conserved during the descent from cartilaginous fishes to humans.  Expression of 
shark MR in many tissues (brain, heart, liver, ovary) in which the MR is not likely to regulate 
electrolyte homeostasis, the MR’s classical function, further supports evidence from the last 
thirty years (3, 17-19, 68, 70-72) that mineralocorticoid activity is an incomplete functional 
description of this nuclear receptor.  An alternative name is needed to describe more completely 
the functions of the MR. 
 
Materials and Methods 
Chemical reagents 
Aldo, F, B, DOC, S, Prog, 19norProg, 17OH-Prog and Spiron were purchased from 
Sigma-Aldrich.  For reporter gene assays, all hormones were dissolved in dimethylsulfoxide 
(DMSO); the final DMSO concentration in the culture medium did not exceed 0.1%. 
Construction of plasmid vectors 
The full-coding regions from elephant shark MR were amplified by PCR with KOD 
DNA polymerase.  The PCR products were gel-purified and ligated into pcDNA3.1 vector 
(Invitrogen) for the full-coding region or pBIND vector for D-E domains (73). 
RNA-sequence analysis 
The RNA-seq reads from following tissues of elephant shark were down-loaded from 
the Sequence Read Archive database of NCBI (accession number SRA054255): brain, gills, 
heart, intestine, kidney, liver, muscle, ovary, spleen, and testis.  For each tissue, sequences were 
assembled de novo using Trinity, version r2013-08-14 (74). 
Gene Expression Analyses 
To determine the expression level of MR genes, we performed abundance estimation 
of transcripts from the afore mentioned 10 tissues. Trinity transcripts from all ten tissues and 
full-length cDNA sequence of the MR gene were combined together and clustered using CD-
HITv4.6.1 at 100% identity (75). RNA-seq reads from each of the ten tissues was independently 
aligned to the clustered transcript sequences and abundance of MR gene transcripts was 
estimated by RSEMv1.2.25 (62) which uses bowtiev2.2.6 for aligning (76). Transcript 
abundances were measured in terms of normalized counts called Fragments per kilobase of exon 
per million fragments mapped (FPKM) (62). FPKM is estimated by normalizing the gene length 
followed by normalizing for sequencing depth. 
Transactivation Assay and Statistical Methods 
Transfection and reporter assays were carried out in HEK293 cells, as described 
previously (73, 77).  All experiments were performed in triplicate.  The values shown are mean ± 
SEM from three separate experiments, and dose-response data and EC50 were analyzed using 
GraphPad Prism.  Comparisons between two groups were performed using t-test, and all multi-
group comparisons were performed using one-way ANOVA followed by Bonferroni test.  P < 
0.05 was considered statistically significant. 
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